Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
News Bird & Bird strengthens Polish Energy & Utilities team with new partner hire

Sep 02 2025

Read More
News Bird & Bird boosts regulatory team in Brussels with double partner hire

Sep 01 2025

Read More
News Bird & Bird hires corporate crime, compliance and ESG expert David Schreuders as new partner

Sep 01 2025

Read More
News Bird & Bird recognised in World IP Review (WIPR) Global Trade Secrets Ranking 2025

Aug 27 2025

Read More
Deal Bird & Bird advised on the sale of Irish suspension specialist Timoney Dynamic Solutions Ltd to Kessler & Co

Aug 27 2025

Read More
Deal Bird & Bird advised Clubber TV on a significant investment by leading European media group Mediahuis

Aug 27 2025

Read More